TWENTE MEDICAL SYSTEMS INTERNATIONAL B.V.

Their core work

TMSI develops and manufactures high-precision biosignal amplifiers and physiological measurement systems used in neuroscience, rehabilitation, and human factors research. Their hardware captures EEG, EMG, ECG, and other electrophysiological signals with high fidelity, serving as the measurement backbone for clinical and research applications. In H2020 projects, they contribute specialized sensing equipment for prosthetics control (SoftPro), driver behavior monitoring (SimuSafe), and infant brain development research (MOTION). As a technology SME, they bridge the gap between laboratory-grade biosignal acquisition and real-world mobile applications.

What they specialise in

How they've shifted over time

With only three projects spanning 2016–2018, the evolution is compressed but visible. Their earliest project (SoftPro, 2016) focused on rehabilitation and prosthetics — a traditional application of biosignal measurement. By 2017–2018, they moved toward more applied, mobile, and population-specific contexts: transport safety simulation (SimuSafe) and infant neuroscience with mobile equipment (MOTION). The trajectory suggests a shift from stationary lab instrumentation toward portable, real-world measurement scenarios.

TMSI is moving toward portable and wearable biosignal solutions for real-world settings beyond the traditional laboratory, making them increasingly relevant for applied health, transport, and field neuroscience projects.

How they like to work

TMSI participates exclusively as a partner, never as coordinator — consistent with their role as a specialist hardware provider embedded in larger research consortia. Across just 3 projects they have worked with 41 unique partners in 14 countries, indicating they integrate easily into diverse international teams. Their value proposition is clear and bounded: they supply the measurement technology, letting academic and clinical partners focus on the science.

Despite only three projects, TMSI has built a broad network of 41 partners across 14 countries, reflecting the large consortium sizes typical of RIA and MSCA-ITN projects. Their geographic reach spans most of the EU, with no single-country concentration.

What sets them apart

TMSI occupies a niche that few European SMEs fill: they are a dedicated manufacturer of research-grade biosignal amplifiers, not a university spin-off or consultancy. This means consortia get a commercial hardware partner with production capability and product support, not just a prototype. For any project requiring precise, multi-channel physiological measurement — whether EEG, EMG, or multimodal — TMSI brings ready-to-deploy instrumentation that bridges research specifications and commercial reliability.

Highlights from their portfolio

• SimuSafe
  Largest EC contribution (EUR 406K) and an unusual cross-sector application combining biosignal measurement with transport safety simulation.
• MOTION
  An MSCA training network focused on infant neuroscience, demonstrating TMSI's ability to adapt measurement technology for vulnerable and non-standard populations.
• SoftPro
  Directly linked to TMSI's core business of EMG acquisition for prosthetics, showing deep domain alignment between company products and project goals.